Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific microRNA

Journal of Virology

Volumn 82, Issue 22, 2008, Pages 11009-11015

  Ylösmäki, Erkko ^a   Hakkarainen, Tanja ^a   Hemminki, Akseli ^a   Visakorpi, Tapio ^b   Andino, Raul ^c   Saksela, Kalle ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

E1A PROTEIN; MICRORNA; MICRORNA 122; ONCOLYTIC ADENOVIRUS; UNCLASSIFIED DRUG; VIRUS MESSENGER RNA; MESSENGER RNA; VIRUS RNA;

3' UNTRANSLATED REGION; ADENOVIRUS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL; LIVER TOXICITY; PRIORITY JOURNAL; RNA SEQUENCE; VIRUS ATTENUATION; VIRUS RECOMBINANT; VIRUS REPLICATION; CELL LINE; DRUG ANTAGONISM; FAMILY SIZE; GENETICS; GROWTH, DEVELOPMENT AND AGING;

ADENOVIRIDAE; DNA VIRUSES; MAMMALIA;

3' UNTRANSLATED REGIONS; ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; CELL LINE; FAMILY CHARACTERISTICS; HUMANS; MICRORNAS; RNA, MESSENGER; RNA, VIRAL; VIRUS REPLICATION;

EID: 55549108699     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01608-08     Document Type: Article

References (46)

1. Aghi, M., and R. L. Martuza. 2005. Oncolytic viral therapies - the clinical experience. Oncogene 24:7802-7816.
2. Ahmed, A., J. Thompson, L. Emiliusen, S. Murphy, R. D. Beauchamp, K. Suzuki, R. Alemany, K. Harrington, and R. G. Vile. 2003. A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization. Nat. Biotechnol. 21:771-777.
3. Alemany, R. 2007. Cancer selective adenoviruses. Mol. Aspects Med. 28:42-58.
4. Ambros, V. 2003. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113:673-676.
5. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
6. Bauerschmitz, G. J., K. Guse, A. Kanerva, A. Menzel, I. Herrmann, R. A. Desmond, M. Yamamoto, D. M. Nettelbeck, T. Hakkarainen, P. Dall, D. T. Curiel, and A. Hemminki. 2006. Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells. Mol. Ther. 14:164-174.
7. Bischoff, J. R., D. H. Kirn, A. Williams, C. Heise, S. Horn, M. Muna, L. Ng, J. A. Nye, A. Sampson-Johannes, A. Fattaey, and F. McCormick. 1996. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373-376.
8. Blenkiron, C., and E. A. Miska. 2007. miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum. Mol. Genet. 16(R1):R106-R113.
9. Brown, B. D., B. Gentner, A. Cantore, S. Colleoni, M. Amendola, A. Zingale, A. Baccarini, G. Lazzari, C. Galli, and L. Naldini. 2007. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat. Biotechnol. 25:1457-1467.
10. Brunetti-Pierri, N., D. J. Palmer, A. L. Beaudet, K. D. Carey, M. Finegold, and P. Ng. 2004. Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum. Gene Ther. 15:35-46.
11. Calin, G. A., and C. M. Croce. 2006. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6:857-866.
12. Chang, J., E. Nicolas, D. Marks, C. Sander, A. Lerro, M. A. Buendia, C. Xu, W. S. Mason, T. Moloshok, R. Bort, K. S. Zaret, and J. M. Taylor. 2004. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 1:106-113.
13. Cullen, B. R. 2004. Transcription and processing of human microRNA precursors. Mol. Cell 16:861-865.
14. Edge, R. E., T. J. Falls, C. W. Brown, B. D. Lichty, H. Atkins, and J. C. Bell. 2008. A let-7 microRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication. Mol. Ther. 16:1437-1443.
15. Esquela-Kerscher, A., and F. J. Slack. 2006. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6:259-269.
16. Fueyo, J., C. Gomez-Manzano, R. Alemany, P. S. Lee, T. J. McDonnell, P. Mitlianga, Y. X. Shi, V. A. Levin, W. K. Yung, and A. P. Kyritsis. 2000. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene 19:2-12.
17. Gitlin, L., J. K. Stone, and R. Andino. 2005. Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J. Virol. 79:1027-1035.
18. Hamid, O., M. L. Varterasian, S. Wadler, J. R. Hecht, A. Benson III, E. Galanis, M. Uprichard, C. Omer, P. Bycott, R. C. Hackman, and A. F. Shields. 2003. Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer. J. Clin. Oncol. 21:1498-1504.
19. Heise, C., T. Hermiston, L. Johnson, G. Brooks, A. Sampson-Johannes, A. Williams, L. Hawkins, and D. Kirn. 2000. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat. Med. 6:1134-1139.
20. Hitt, M. M., and F. L. Graham. 1990. Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replication. Virology 179:667-678.
21. Hsu, P. W., H. D. Huang, S. D. Hsu, L. Z. Lin, A. P. Tsou, C. P. Tseng, P. F. Stadler, S. Washietl, and I. L. Hofacker. 2006. miRNAMap: genomic maps of microRNA genes and their target genes in mammalian genomes. Nucleic Acids Res. 34:D135-D139.
22. Jay, C., J. Nemunaitis, P. Chen, P. Fulgham, and A. W. Tong. 2007. miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol. 26:293-300.
23. John, B., A. J. Enright, A. Aravin, T. Tuschl, C. Sander, and D. S. Marks. 2004. Human microRNA targets. PLoS Biol. 2:e363.
24. John, B., C. Sander, and D. S. Marks. 2006. Prediction of human microRNA targets. Methods Mol. Biol. 342:101-113.
25. Kanerva, A., and A. Hemminki. 2004. Modified adenoviruses for cancer gene therapy. Int. J. Cancer 110:475-480.
26. Kanerva, A., G. V. Mikheeva, V. Krasnykh, C. J. Coolidge, J. T. Lam, P. J. Mahasreshti, S. D. Barker, M. Straughn, M. N. Barnes, R. D. Alvarez, A. Hemminki, and D. T. Curiel. 2002. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Clin. Cancer Res. 8:275-280.
27. Kim, V. N., and J. W. Nam. 2006. Genomics of microRNA. Trends Genet. 22:165-173.
28. Kozak, M. 1986. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292.
29. Lagos-Quintana, M., R. Rauhut, A. Yalcin, J. Meyer, W. Lendeckel, and T. Tuschl. 2002. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12:735-739.
30. Lin, E., and J. Nemunaitis. 2004. Oncolytic viral therapies. Cancer Gene Ther. 11:643-664.
31. Liu, C. G., G. A. Calin, B. Meloon, N. Gamliel, C. Sevignani, M. Ferracin, C. D. Dumitru, M. Shimizu, S. Zupo, M. Dono, H. Alder, F. Bullrich, M. Negrini, and C. M. Croce. 2004. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc. Natl. Acad. Sci. USA 101:9740-9744.
32. Lu, J., G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B. L. Ebert, R. H. Mak, A. A. Ferrando, J. R. Downing, T. Jacks, H. R. Horvitz, and T. R. Golub. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834-838.
33. Mansfield, J. H., B. D. Harfe, R. Nissen, J. Obenauer, J. Srineel, A. Chaudhuri, R. Farzan-Kashani, M. Zuker, A. E. Pasquinelli, G. Ruvkun, P. A. Sharp, C. J. Tabin, and M. T. McManus. 2004. MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nat. Genet. 36:1079-1083.
34. Mathis, J. M., M. A. Stoff-Khalili, and D. T. Curiel. 2005. Oncolytic adenoviruses - selective retargeting to tumor cells. Oncogene 24:7775-7791.
35. Matranga, C., and P. D. Zamore. 2007. Small silencing RNAs. Curr. Biol. 17:R789-R793.
36. Morral, N., W. K. O'Neal, K. Rice, M. M. Leland, P. A. Piedra, E. Aguilar-Cordova, K. D. Carey, A. L. Beaudet, and C. Langston. 2002. Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum. Gene Ther. 13:143-154.
37. O'Shea, C. C., L. Johnson, B. Bagus, S. Choi, C. Nicholas, A. Shen, L. Boyle, K. Pandey, C. Soria, J. Kunich, Y. Shen, G. Habets, D. Ginzinger, and F. McCormick. 2004. Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity. Cancer Cell 6:611-623.
38. Raper, S. E., N. Chirmule, F. S. Lee, N. A. Wivel, A. Bagg, G. P. Gao, J. M. Wilson, and M. L. Batshaw. 2003. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80:148-158.
39. Reid, T., E. Galanis, J. Abbruzzese, D. Sze, J. Andrews, L. Romel, M. Hatfield, J. Rubin, and D. Kirn. 2001. Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. Gene Ther. 8:1618-1626.
40. Rodriguez, R., E. R. Schuur, H. Y. Lim, G. A. Henderson, J. W. Simons, and D. R. Henderson. 1997. Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res. 57:2559-2563.
41. Saukkonen, K., and A. Hemminki. 2004. Tissue-specific promoters for cancer gene therapy. Expert Opin. Biol. Ther. 4:683-696.
42. Sood, P., A. Krek, M. Zavolan, G. Macino, and N. Rajewsky. 2006. Cell-type-specific signatures of microRNAs on target mRNA expression. Proc. Natl. Acad. Sci. USA 103:2746-2751.
43. Stoff-Khalili, M. A., A. A. Rivera, A. Nedeljkovic-Kurepa, A. Debenedetti, X. L. Li, Y. Odaka, J. Podduturi, D. A. Sibley, G. P. Siegal, A. Stoff, S. Young, Z. B. Zhu, D. T. Curiel, and J. M. Mathis. 2008. Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control. Breast Cancer Res. Treat. 108:43-55.
44. Vähä-Koskela, M. J., J. E. Heikkilä, and A. E. Hinkkanen. 2007. Oncolytic viruses in cancer therapy. Cancer Lett. 254:178-216.
45. Volinia, S., G. A. Calin, C. G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R. L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C. C. Harris, and C. M. Croce. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103:2257-2261.
46. Yu, S. L., H. Y. Chen, P. C. Yang, and J. J. Chen. 2007. Unique microRNA signature and clinical outcome of cancers. DNA Cell Biol. 26:283-292.